Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Shattock, F. Mackenzie
1950.
The Somatic Manifestations of Schizophrenia.
Journal of Mental Science,
Vol. 96,
Issue. 402,
p.
32.
Sandison, R. A.
Spencer, A. M.
and
Whitelaw, J. D. A.
1954.
The Therapeutic Value of Lysergic Acid Diethylamide in Mental Illness.
Journal of Mental Science,
Vol. 100,
Issue. 419,
p.
491.
Denber, Herman C. B.
and
Merlis, Sidney
1954.
A note on some therapeutic implications of the mescaline-induced state.
The Psychiatric Quarterly,
Vol. 28,
Issue. 1-4,
p.
635.
Denber, Herman C. B.
and
Merlis, Sidney
1955.
Studies on mescaline I. Action in schizophrenic patients.
The Psychiatric Quarterly,
Vol. 29,
Issue. 1-4,
p.
421.
Peretz, Dwight I.
Smythies, John R.
and
Gibson, William C.
1955.
A New Hallucinogen: 3,4,5-Trimethoxyphenyl-β-Aminopropane.
Journal of Mental Science,
Vol. 101,
Issue. 423,
p.
317.
Beecher, Henry K.
1958.
Psychotomimetic drugs.
Journal of Chronic Diseases,
Vol. 8,
Issue. 2,
p.
253.
Koelle, George B.
1958.
The Pharmacology of Mescaline and D-Lysergic Acid Diethylamide (LSD).
New England Journal of Medicine,
Vol. 258,
Issue. 1,
p.
25.
Hoch, Paul H.
1960.
Methods and analysis of drug induced abnormal mental states in man.
Comprehensive Psychiatry,
Vol. 1,
Issue. 5,
p.
265.
Davies, Brian M.
and
Beech, H. R.
1960.
The Effect of 1-Arylcyclohexylamine (Sernyl) on Twelve Normal Volunteers.
Journal of Mental Science,
Vol. 106,
Issue. 444,
p.
912.
Marley, Edward
1960.
Response to Some Stimulant and Depressant Drugs of the Central Nervous System.
Journal of Mental Science,
Vol. 106,
Issue. 442,
p.
76.
Hoffer, A.
and
Callbeck, M. J.
1960.
Drug-Induced Schizophrenia.
Journal of Mental Science,
Vol. 106,
Issue. 442,
p.
138.
Ban, T. A.
Lohrenz, J. J.
and
Lehmann, H. E.
1961.
Observations on the Action of Sernyl — A New Psychotropic Drug.
Canadian Psychiatric Association Journal,
Vol. 6,
Issue. 3,
p.
150.
Wolbach, A. B.
Isbell, Harris
and
Miner, E. J.
1962.
Cross tolerance between mescaline and LSD-25 with a comparison of the mescaline and LSD reactions.
Psychopharmacologia,
Vol. 3,
Issue. 1,
p.
1.
Hoffer, A.
1962.
International Review of Neurobiology Volume 4.
Vol. 4,
Issue. ,
p.
307.
LEWIS, J. J.
RITCHIE, A. P.
and
VAN PETTEN, G. R.
1965.
THE INFLUENCE OF HALLUCINOGENIC DRUGS UPON IN VIVO BRAIN LEVELS OF ADENINE NUCLEOTIDES, PHOSPHOCREATINE AND INORGANIC PHOSPHATE IN THE RAT.
British Journal of Pharmacology and Chemotherapy,
Vol. 25,
Issue. 3,
p.
631.
Faillace, Louis A.
1966.
Clinical use of psychotomimetic drugs.
Comprehensive Psychiatry,
Vol. 7,
Issue. 1,
p.
13.
Hoffer, A.
and
Osmond, H.
1967.
The Hallucinogens.
p.
1.
Weil‐Malherbe, H.
1967.
Advances in Enzymology and Related Areas of Molecular Biology.
Vol. 29,
Issue. ,
p.
479.
Johnston, V. S.
and
Bradley, R. J.
1968.
Recent Advances in Biological Psychiatry.
p.
74.
Hardman, Harold F.
Haavik, Coryce O.
and
Seevers, Maurice H.
1973.
Relationship of the structure of mescaline and seven analogs to toxicity and behavior in five species of laboratory animals.
Toxicology and Applied Pharmacology,
Vol. 25,
Issue. 2,
p.
299.
eLetters
No eLetters have been published for this article.